E-LIB Suche - Ergebnisse für: Warnakula Olesen, Kevin Kris

1

Non-HDL cholesterol and residual risk of cardiovascular eve..:

Hansen, Malene Kærslund ; Mortensen, Martin Bødtker ; Warnakula Olesen, Kevin Kris..
The Lancet Regional Health - Europe. 36 (2024) - p. 100774 , 2024

Link: https://doi.org/10.1016/..

2

Ten-year patterns of stent thrombosis after percutaneous co..:

Coughlan, John Joseph ; Maeng, Michael ; Räber, Lorenz...
Revista Española de Cardiología (English Edition). 75 (2022) 11 - p. 894-902 , 2022

Link: https://doi.org/10.1016/..

3

Non-HDL cholesterol and residual cardiovascular risk in sta..:

Hansen, Malene Kærslund ; Mortensen, Martin Bødtker ; Olesen, Kevin Kris Warnakula...
European Journal of Preventive Cardiology. , 2024

Link: https://doi.org/10.1093/..

4

Net clinical benefit of extended dual pathway inhibition ac..:

Würtz, Morten ; Olesen, Kevin Kris Warnakula ; Bhatt, Deepak L...
European Heart Journal - Cardiovascular Pharmacotherapy. 10 (2024) 3 - p. 201-209 , 2024

Link: https://doi.org/10.1093/..

5

Coronary Artery Disease Is A Stronger Predictor of All‐Caus..:

Nielsen, Roni Ranghoej ; Pryds, Kasper ; Olesen, Kevin Kris Warnakula...
Journal of the American Heart Association. , 2024

Link: https://doi.org/10.1161/..

6

Effectiveness and Safety of Ticagrelor Implementation in Pa..:

Thrane, Pernille Gro ; Olesen, Kevin Kris Warnakula ; Würtz, Morten...
The Lancet Regional Health - Europe. 14 (2022) - p. 100301 , 2022

Link: https://doi.org/10.1016/..

7

Microvascular disease increases the risk of lower limb ampu..:

Olesen, Kevin Kris Warnakula ; Anand, Sonia ; Thim, Troels..
European Journal of Clinical Investigation. 52 (2022) 10 - p. , 2022

Link: https://doi.org/10.1111/..

8

Ten-year cardiovascular risk in diabetes patients without o..:

Olesen, Kevin Kris Warnakula ; Madsen, Morten ; Gyldenkerne, Christine...
Cardiovascular Diabetology. 20 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

9

Insulin-treated versus noninsulin-treated diabetes and risk..:

Jensen, Thomas ; Olesen, Kevin Kris Warnakula ; De Caterina, Raffaele...
Vascular Pharmacology. 136 (2021) - p. 106809 , 2021

Link: https://doi.org/10.1016/..

10

Risk of Myocardial Infarction and Death After Noncardiac Su..:

Thim, Troels ; Egholm, Gro ; Kristensen, Steen Dalby...
The American Journal of Cardiology. 160 (2021) - p. 14-20 , 2021

Link: https://doi.org/10.1016/..

11

Cardiovascular risk in patients with and without diabetes p..:

Jensen, Esben Skov ; Olesen, Kevin Kris Warnakula ; Gyldenkerne, Christine...
BMC Cardiovascular Disorders. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

12

CHA2DS2‐VASc impact on risk following percutaneous coronary..:

Jensen, Thomas ; Thrane, Pernille Gro ; Olesen, Kevin Kris Warnakula...
European Journal of Clinical Investigation. 52 (2021) 4 - p. , 2021

Link: https://doi.org/10.1111/..

13

Thirteen-year trends in cardiovascular risk in men and wome..:

Olesen, Kevin Kris Warnakula ; Jensen, Esben Skov ; Gyldenkerne, Christine...
European Heart Journal - Quality of Care and Clinical Outcomes. 8 (2021) 4 - p. 437-446 , 2021

Link: https://doi.org/10.1093/..

14

Peripheral artery disease, lower limb revascularization, an..:

Olesen, Kevin Kris Warnakula ; Gyldenkerne, Christine ; Thim, Troels..
BMJ Open Diabetes Research & Care. 9 (2021) 1 - p. e001803 , 2021

Link: https://doi.org/10.1136/..

15

Dual antithrombotic treatment in chronic coronary syndrome:..:

Würtz, Morten ; Olesen, Kevin Kris Warnakula ; Mortensen, Martin Bødtker...
European Heart Journal. 43 (2021) 10 - p. 996-1004 , 2021

Link: https://doi.org/10.1093/..